5AM Venture Management’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-541,666
Closed -$2.45M 22
2025
Q3
$2.45M Hold
541,666
0.9% 22
2025
Q2
$1.16M Hold
541,666
0.45% 27
2025
Q1
$2.37M Hold
541,666
0.9% 26
2024
Q4
$2.53M Hold
541,666
0.6% 27
2024
Q3
$3.8M Hold
541,666
0.79% 25
2024
Q2
$3.72M Hold
541,666
0.83% 24
2024
Q1
$7.66M Buy
+541,666
New +$8.24M 1.71% 19

5AM Venture Management's ADVM Position: Q4 2025 in Review

5AM Venture Management sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 541,666 shares — an estimated $2.45M sold.

5AM Venture Management first reported a position in ADVM in Q1 2024 and held it in 7 quarters. The position peaked at $7.66M in Q1 2024. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

  • 5AM Venture Management reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • 5AM Venture Management sold 541,666 Adverum Biotechnologies shares in Q4 2025, an estimated $2.45M.
  • 5AM Venture Management first reported a position in Adverum Biotechnologies in Q1 2024 and held it in 7 quarters.
  • 5AM Venture Management's Adverum Biotechnologies position peaked at $7.66M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on 5AM Venture Management's 13F filing for Q4 2025, filed 17 Feb 2026.